Sinovac Biotech Ltd Strategic Asset Allocation Index
Sinovac Biotech Ltd strategic asset allocation index. Sinovac Biotech Ltd (SVA) has a Strategic Asset Allocation Index of 8.9% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $576.09 Million) total $576.09 Million, measured against net assets of $6.46 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check SVA tangible net worth ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Sinovac Biotech Ltd (2002–2025)
Strategic asset allocation index of Sinovac Biotech Ltd from 2002 to 2025. This chart shows how Sinovac Biotech Ltd's Strategic Asset Allocation Index has evolved across 24 annual periods from 2002 to 2025. As of June 2026, the index stands at 8.9%, representing strategic assets of $576.09 Million against net assets of $6.46 Billion USD.
Sinovac Biotech Ltd Strategic Asset Allocation Index by Year (2002–2025)
Sinovac Biotech Ltd strategic asset allocation index by year from 2002 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Sinovac Biotech Ltd from 2002 to 2025, covering 24 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see SVA market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 8.0% | $512.32 Million | $- | $512.32 Million | $6.40 Billion | ▲ +3.2 pp |
| 2024 | 4.8% | $491.35 Million | $- | $491.35 Million | $10.29 Billion | ▼ -0.9 pp |
| 2023 | 5.7% | $684.28 Million | $- | $684.28 Million | $12.02 Billion | ▲ +0.5 pp |
| 2022 | 5.2% | $661.44 Million | $- | $661.44 Million | $12.71 Billion | ▲ +0.5 pp |
| 2021 | 4.7% | $655.84 Million | $- | $655.84 Million | $13.88 Billion | ▼ -20.6 pp |
| 2020 | 25.4% | $284.20 Million | $284.20 Million | $0.00 | $1.12 Billion | ▲ +2.4 pp |
| 2019 | 23.0% | $80.95 Million | $80.95 Million | $- | $352.19 Million | ▼ -1.3 pp |
| 2018 | 24.3% | $70.92 Million | $70.92 Million | $0.00 | $291.93 Million | ▼ -34.7 pp |
| 2017 | 58.9% | $76.43 Million | $76.43 Million | $0.00 | $129.67 Million | ▲ +7.4 pp |
| 2016 | 51.6% | $66.88 Million | $66.88 Million | $0.00 | $129.67 Million | ▲ +4.8 pp |
| 2015 | 46.8% | $63.91 Million | $63.91 Million | $0.00 | $136.50 Million | ▼ -1.5 pp |
| 2014 | 48.3% | $68.42 Million | $68.42 Million | $- | $141.73 Million | ▲ +1.0 pp |
| 2013 | 47.3% | $67.96 Million | $67.96 Million | $- | $143.64 Million | ▼ -14.6 pp |
| 2012 | 61.9% | $80.08 Million | $80.08 Million | $- | $129.44 Million | ▲ +9.8 pp |
| 2011 | 52.1% | $75.63 Million | $75.63 Million | $- | $145.30 Million | ▲ +8.7 pp |
| 2010 | 43.3% | $64.04 Million | $64.04 Million | $- | $147.76 Million | ▲ +16.9 pp |
| 2009 | 26.4% | $22.31 Million | $22.31 Million | $- | $84.47 Million | ▼ -9.5 pp |
| 2008 | 35.9% | $19.26 Million | $19.26 Million | $- | $53.64 Million | ▼ -12.3 pp |
| 2007 | 48.3% | $15.88 Million | $15.88 Million | $- | $32.90 Million | ▼ -12.9 pp |
| 2006 | 61.1% | $13.03 Million | $13.03 Million | $- | $21.31 Million | ▼ -14.3 pp |
| 2005 | 75.5% | $12.46 Million | $12.46 Million | $- | $16.51 Million | ▲ +10.9 pp |
| 2004 | 64.5% | $10.04 Million | $10.04 Million | $- | $15.56 Million | ▼ -4.0 pp |
| 2003 | 68.5% | $7.46 Million | $7.46 Million | $- | $10.89 Million | ▲ +61.5 pp |
| 2002 | 7.0% | $7.00K | $7.00K | $- | $99.44K | — |